Detalles de la búsqueda
1.
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Circulation
; 129(6): 625-34, 2014 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-24226808
2.
Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial.
Am Heart J
; 169(4): 531-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819860
3.
Apixaban versus warfarin in patients with atrial fibrillation.
N Engl J Med
; 365(11): 981-92, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21870978
4.
Apixaban with antiplatelet therapy after acute coronary syndrome.
N Engl J Med
; 365(8): 699-708, 2011 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21780946
5.
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Lancet
; 380(9855): 1749-58, 2012 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23036896
6.
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitor.
J Thromb Thrombolysis
; 32(2): 183-7, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21516308
7.
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
Circulation
; 119(22): 2877-85, 2009 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19470889
8.
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
J Am Coll Cardiol
; 72(7): 721-733, 2018 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30092948
9.
Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation.
Ann N Y Acad Sci
; 1329: 93-106, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25377080
10.
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
J Am Coll Cardiol
; 63(11): 1082-7, 2014 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24211508
11.
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.
Lancet Neurol
; 11(6): 503-11, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22572202
12.
Apixaban decreases coagulation activity in patients with acute deep-vein thrombosis.
Thromb Haemost
; 105(1): 181-9, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20941459
13.
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
Thromb Haemost
; 104(5): 976-83, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20806117
Resultados
1 -
13
de 13
1
Próxima >
>>